# FDC Ltd (FDC)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹362.4
Day Change: -0.33%
52W High: ₹527.8
52W Low: ₹312.95
Market Cap: ₹5,892 Cr

## Valuation
P/E: 27.23
P/B: 2.41
EPS: ₹13.29
Book Value: ₹149.97
Dividend Yield: 1.37%

## Returns
1Y Return: -11.12%

## Profitability
ROE: 0%
ROCE: 14.07%
Debt/Equity: 0.01
Revenue Growth: 0.1%
Profit Growth: -23.7%
EBITDA Margin: 13.28%
Operating Margin: 8.07%

## About
FDC Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: FDC Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Newspaper Publication - Corrigendum In Respect Of Postal Ballot Notice Dated 21St April, 2026
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:01.518Z
Price History Updated: 2026-05-18T22:58:35.994Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:35.994Z
Quant Updated: 2026-05-18T22:58:35.994Z
Sentiment Updated: 2026-05-18T22:58:35.994Z
Financials Status: current
Financials Updated: 2026-05-18T12:31:41.019Z
Financials Last Attempt: 2026-05-18T12:31:41.019Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹845 Cr
Operating Profit: ₹207 Cr (OPM 24%)
Net Profit: ₹135 Cr
Tax: ₹218 Cr

## Annual P&L History
Mar 2015: Rev ₹845Cr | PAT ₹135Cr | OPM 24%
Mar 2016: Rev ₹888Cr | PAT ₹148Cr | OPM 22%
Mar 2017: Rev ₹994Cr | PAT ₹169Cr | OPM 23%

## Balance Sheet (Mar 2015)
Total Assets: ₹1059 Cr
Total Liabilities: ₹1059 Cr
Borrowings: ₹3 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Mohan Anand Chandavarkar, Chairman, BR Head & MD
- Nandan Mohan Chandavarkar, Joint MD & Executive Director
- Ameya Ashok Chandavarkar, CEO of International Business & Executive Director
- Ashok Anand Chandavarkar, Executive Director
- Vishal  Shah, Chief Financial Officer

---
Source: rupiya.io/stocks/fdc
Disclaimer: For research and education only. Not investment advice.